248 related articles for article (PubMed ID: 23877104)
21. Uptake of cardiovascular drugs into the human heart: expression, regulation, and function of the carnitine transporter OCTN2 (SLC22A5).
Grube M; Meyer zu Schwabedissen HE; Präger D; Haney J; Möritz KU; Meissner K; Rosskopf D; Eckel L; Böhm M; Jedlitschky G; Kroemer HK
Circulation; 2006 Feb; 113(8):1114-22. PubMed ID: 16490820
[TBL] [Abstract][Full Text] [Related]
22. Short communication: the pharmacological peroxisome proliferator-activated receptor α agonist WY-14,643 increases expression of novel organic cation transporter 2 and carnitine uptake in bovine kidney cells.
Zhou X; Wen G; Ringseis R; Eder K
J Dairy Sci; 2014; 97(1):345-9. PubMed ID: 24210485
[TBL] [Abstract][Full Text] [Related]
23. Na(+)-coupled transport of L-carnitine via high-affinity carnitine transporter OCTN2 and its subcellular localization in kidney.
Tamai I; China K; Sai Y; Kobayashi D; Nezu J; Kawahara E; Tsuji A
Biochim Biophys Acta; 2001 Jun; 1512(2):273-84. PubMed ID: 11406104
[TBL] [Abstract][Full Text] [Related]
24. Caveolin-1--a novel interacting partner of organic cation/carnitine transporter (Octn2): effect of protein kinase C on this interaction in rat astrocytes.
Czeredys M; Samluk Ł; Michalec K; Tułodziecka K; Skowronek K; Nałęcz KA
PLoS One; 2013; 8(12):e82105. PubMed ID: 24349196
[TBL] [Abstract][Full Text] [Related]
25. Tight junction protein ZO-1 controls organic cation/carnitine transporter OCTN2 (SLC22A5) in a protein kinase C-dependent way.
Jurkiewicz D; Michalec K; Skowronek K; Nałęcz KA
Biochim Biophys Acta Mol Cell Res; 2017 May; 1864(5):797-805. PubMed ID: 28257821
[TBL] [Abstract][Full Text] [Related]
26. The pro-inflammatory cytokine tumor necrosis factor α stimulates expression of the carnitine transporter OCTN2 (novel organic cation transporter 2) and carnitine uptake via nuclear factor-κB in Madin-Darby bovine kidney cells.
Zhou X; Ringseis R; Wen G; Eder K
J Dairy Sci; 2015 Jun; 98(6):3840-8. PubMed ID: 25892691
[TBL] [Abstract][Full Text] [Related]
27. Characterization of Aripiprazole Uptake Transporter in the Blood-Brain Barrier Model hCMEC/D3 Cells by Targeted siRNA Screening.
Kadoguchi M; Arakawa H; Honda R; Hotta K; Shirasaka Y; Deguchi Y; Tamai I
Pharm Res; 2022 Jul; 39(7):1549-1559. PubMed ID: 35314999
[TBL] [Abstract][Full Text] [Related]
28. The activity and surface presence of organic cation/carnitine transporter OCTN2 (SLC22A5) in breast cancer cells depends on AKT kinase.
Papierniak-Wyglądała A; Lamch W; Jurewicz E; Nałęcz KA
Arch Biochem Biophys; 2023 Jul; 742():109616. PubMed ID: 37187422
[TBL] [Abstract][Full Text] [Related]
29. Functional genetic diversity in the high-affinity carnitine transporter OCTN2 (SLC22A5).
Urban TJ; Gallagher RC; Brown C; Castro RA; Lagpacan LL; Brett CM; Taylor TR; Carlson EJ; Ferrin TE; Burchard EG; Packman S; Giacomini KM
Mol Pharmacol; 2006 Nov; 70(5):1602-11. PubMed ID: 16931768
[TBL] [Abstract][Full Text] [Related]
30. Expression of OCTN2 and OCTN3 in the apical membrane of rat renal cortex and medulla.
Cano MM; Calonge ML; Ilundain AA
J Cell Physiol; 2010 May; 223(2):451-9. PubMed ID: 20112288
[TBL] [Abstract][Full Text] [Related]
31. Pharmacological and pathophysiological roles of carnitine/organic cation transporters (OCTNs: SLC22A4, SLC22A5 and Slc22a21).
Tamai I
Biopharm Drug Dispos; 2013 Jan; 34(1):29-44. PubMed ID: 22952014
[TBL] [Abstract][Full Text] [Related]
32. The carnitine transporter SLC22A5 is not a general drug transporter, but it efficiently translocates mildronate.
Grigat S; Fork C; Bach M; Golz S; Geerts A; Schömig E; Gründemann D
Drug Metab Dispos; 2009 Feb; 37(2):330-7. PubMed ID: 18981167
[TBL] [Abstract][Full Text] [Related]
33. Colistin is substrate of the carnitine/organic cation transporter 2 (OCTN2, SLC22A5).
Visentin M; Gai Z; Torozi A; Hiller C; Kullak-Ublick GA
Drug Metab Dispos; 2017 Dec; 45(12):1240-1244. PubMed ID: 28986476
[TBL] [Abstract][Full Text] [Related]
34. Expression and localization of carnitine/organic cation transporter OCTN1 and OCTN2 in ocular epithelium.
Garrett Q; Xu S; Simmons PA; Vehige J; Flanagan JL; Willcox MD
Invest Ophthalmol Vis Sci; 2008 Nov; 49(11):4844-9. PubMed ID: 18641280
[TBL] [Abstract][Full Text] [Related]
35. Studies on functional sites of organic cation/carnitine transporter OCTN2 (SLC22A5) using a Ser467Cys mutant protein.
Ohashi R; Tamai I; Inano A; Katsura M; Sai Y; Nezu J; Tsuji A
J Pharmacol Exp Ther; 2002 Sep; 302(3):1286-94. PubMed ID: 12183691
[TBL] [Abstract][Full Text] [Related]
36. Glycosylation of the OCTN2 carnitine transporter: study of natural mutations identified in patients with primary carnitine deficiency.
Filippo CA; Ardon O; Longo N
Biochim Biophys Acta; 2011 Mar; 1812(3):312-20. PubMed ID: 21126579
[TBL] [Abstract][Full Text] [Related]
37. Protein phosphatase PP2A - a novel interacting partner of carnitine transporter OCTN2 (SLC22A5) in rat astrocytes.
Juraszek B; Nałęcz KA
J Neurochem; 2016 Nov; 139(4):537-551. PubMed ID: 27537937
[TBL] [Abstract][Full Text] [Related]
38. Carnitine/organic cation transporter OCTN2 (Slc22a5) is responsible for renal secretion of cephaloridine in mice.
Kano T; Kato Y; Ito K; Ogihara T; Kubo Y; Tsuji A
Drug Metab Dispos; 2009 May; 37(5):1009-16. PubMed ID: 19220985
[TBL] [Abstract][Full Text] [Related]
39. Pharmacological manipulation of L-carnitine transport into L6 cells with stable overexpression of human OCTN2.
Todesco L; Bur D; Brooks H; Török M; Landmann L; Stieger B; Krähenbühl S
Cell Mol Life Sci; 2008 May; 65(10):1596-608. PubMed ID: 18408886
[TBL] [Abstract][Full Text] [Related]
40. Functional expression of the organic cation/carnitine transporter 2 in rat astrocytes.
Inazu M; Takeda H; Maehara K; Miyashita K; Tomoda A; Matsumiya T
J Neurochem; 2006 Apr; 97(2):424-34. PubMed ID: 16539668
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
